Glioblastoma Clinical Trials in Rozzano
2 recruitingRozzano, Italy
Showing 1–2 of 2 trials
Recruiting
Phase 3
EF-41/KEYNOTE D58: Phase 3 Study of Optune Concomitant With Temozolomide Plus Pembrolizumab in Newly Diagnosed Glioblastoma
Glioblastoma
NovoCure GmbH741 enrolled82 locationsNCT06556563
Recruiting
Not Applicable
Imaging and Biological Markers for Prediction and Identification of Glioblastoma Pseudoprogression: a Prospective Study.
Glioblastoma
Istituto Clinico Humanitas75 enrolled1 locationNCT06113705